Subtopic Deep Dive
Lycorine Biological Activities
Research Guide
What is Lycorine Biological Activities?
Lycorine biological activities encompass the antiviral, antitumor, anti-inflammatory, and acetylcholinesterase inhibitory effects of this Amaryllidaceae alkaloid, targeting protein synthesis, autophagy, and viral replication pathways.
Lycorine demonstrates potent anticancer activity by downregulating HMGB1 to inhibit autophagy in multiple myeloma (Roy et al., 2016, 115 citations) and inducing G0/G1 cell-cycle arrest via HDAC inhibition in K562 cells (Li et al., 2012, 92 citations). It exhibits antiviral effects against SARS-CoV and H5N1 influenza by inhibiting RNP nuclear export (Verma et al., 2020, 137 citations; Chen et al., 2012, 98 citations). Reviews highlight its broad pharmacological profile, including AChE inhibition for Alzheimer's therapy (Murray et al., 2013, 329 citations). Over 20 papers document these activities since 2012.
Why It Matters
Lycorine's antitumor effects enhance bortezomib efficacy in multiple myeloma via HMGB1 downregulation and autophagy inhibition (Roy et al., 2016), positioning it as a lead for drug-resistant cancers. Antiviral properties target SARS-CoV-2 and H5N1 by blocking viral RNP export (Verma et al., 2020; Chen et al., 2012), offering natural product alternatives amid antimicrobial resistance. AChE inhibition supports Alzheimer's therapy development (Murray et al., 2013), while semisynthetic modifications improve bioavailability for clinical translation (Cao et al., 2013). These activities drive drug discovery from Amaryllidaceae alkaloids (Takos and Rook, 2013).
Key Research Challenges
Low Oral Bioavailability
Lycorine's poor pharmacokinetics limits systemic efficacy despite strong in vitro activities (Cao et al., 2013). Semisynthetic derivatives aim to enhance absorption, but optimal modifications remain unestablished (Roy et al., 2018). Clinical translation requires improved delivery strategies.
Molecular Target Identification
Precise mechanisms like HDAC inhibition (Li et al., 2012) and HMGB1 downregulation (Roy et al., 2016) need fuller elucidation for selectivity. Off-target effects in antiviral action against H5N1 and SARS-CoV complicate specificity (Chen et al., 2012; Verma et al., 2020).
Clinical Efficacy Validation
Preclinical antitumor and anti-inflammatory data (Thawabteh et al., 2019; Fürst, 2016) lack large-scale trials. Dose-response optimization and toxicity profiling are essential for Alzheimer's applications via AChE inhibition (Murray et al., 2013).
Essential Papers
Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
Ana Paula Murray, María Belén Faraoni, Marián Castro et al. · 2013 · Current Neuropharmacology · 329 citations
As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheimer's disease, efforts are being made in search of new molecules with anti-AChE activity. The fact that natu...
The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens
Amin Mahmood Thawabteh, Salma Juma, Mariam Bader et al. · 2019 · Toxins · 315 citations
The growing incidence of microorganisms that resist antimicrobials is a constant concern for the scientific community, while the development of new antimicrobials from new chemical entities has bec...
Lycorine: A prospective natural lead for anticancer drug discovery
Mridul Roy, Long Liang, Xiaojuan Xiao et al. · 2018 · Biomedicine & Pharmacotherapy · 163 citations
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
Surjeet Verma, Danielle Twilley, Tenille Esmear et al. · 2020 · Frontiers in Pharmacology · 137 citations
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), known to cause the disease COVID-19, was declared a pandemic in early 2020. The objective of this review was to collate information...
Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
Mridul Roy, Long Liang, Xiaojuan Xiao et al. · 2016 · Theranostics · 115 citations
Multiple myeloma (MM) is largely incurable and drug-resistant. Novel therapeutic approaches such as inhibiting autophagy or rational drug combinations are aimed to overcome this issue. In this stud...
Towards a Molecular Understanding of the Biosynthesis of Amaryllidaceae Alkaloids in Support of Their Expanding Medical Use
Adam M. Takos, Fred Rook · 2013 · International Journal of Molecular Sciences · 102 citations
The alkaloids characteristically produced by the subfamily Amaryllidoideae of the Amaryllidaceae, bulbous plant species that include well know genera such as Narcissus (daffodils) and Galanthus (sn...
Multiple biological functions and pharmacological effects of lycorine
Zhifei Cao, Ping Yang, Quansheng Zhou · 2013 · Science China Chemistry · 101 citations
Reading Guide
Foundational Papers
Start with Murray et al. (2013, 329 citations) for AChE inhibition context and Cao et al. (2013, 101 citations) for comprehensive pharmacological functions, as they establish lycorine's therapeutic foundation.
Recent Advances
Study Roy et al. (2018, 163 citations) for anticancer leads, Verma et al. (2020, 137 citations) for SARS-CoV-2 potential, and Thawabteh et al. (2019, 315 citations) for broad bioactivities against pathogens.
Core Methods
Core techniques include cell-cycle analysis and HDAC assays (Li et al., 2012), autophagy inhibition via HMGB1 (Roy et al., 2016), RNP export immunofluorescence (Chen et al., 2012), and AChE enzymatic inhibition (Murray et al., 2013).
How PapersFlow Helps You Research Lycorine Biological Activities
Discover & Search
Research Agent uses searchPapers and exaSearch to retrieve 250M+ OpenAlex papers on lycorine activities, chaining to citationGraph for high-impact works like Roy et al. (2016, 115 citations) and findSimilarPapers for related alkaloids. This uncovers hidden connections in antiviral mechanisms from Verma et al. (2020).
Analyze & Verify
Analysis Agent employs readPaperContent on Roy et al. (2016) to extract HMGB1-autophagy data, verifies claims with CoVe chain-of-verification, and runs PythonAnalysis for dose-response stats from Li et al. (2012) using pandas/matplotlib. GRADE grading scores evidence strength for clinical relevance in Murray et al. (2013).
Synthesize & Write
Synthesis Agent detects gaps in bioavailability studies across Cao et al. (2013) and Roy et al. (2018), flags contradictions in antiviral targets. Writing Agent applies latexEditText and latexSyncCitations to draft reviews, uses latexCompile for publication-ready manuscripts with exportMermaid diagrams of lycorine pathways.
Use Cases
"Extract IC50 values for lycorine vs. multiple myeloma cell lines from recent papers"
Research Agent → searchPapers('lycorine multiple myeloma IC50') → Analysis Agent → readPaperContent(Roy et al. 2016) → runPythonAnalysis(pandas extraction, matplotlib plots) → CSV table of dose-responses with GRADE scores.
"Draft LaTeX review on lycorine anticancer mechanisms citing top 10 papers"
Research Agent → citationGraph('lycorine antitumor') → Synthesis Agent → gap detection → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF) with pathway exportMermaid.
"Find GitHub repos analyzing lycorine AChE inhibition simulations"
Research Agent → searchPapers('lycorine AChE docking') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(reproduce molecular dynamics from Murray et al. 2013).
Automated Workflows
Deep Research workflow scans 50+ lycorine papers via searchPapers → citationGraph → structured report on activities (antiviral/antitumor). DeepScan applies 7-step CoVe analysis to verify Roy et al. (2016) autophagy claims with GRADE checkpoints and Python stats. Theorizer generates hypotheses on semisynthetic derivatives from Cao et al. (2013) and Takos/Rook (2013) biosynthesis data.
Frequently Asked Questions
What defines lycorine biological activities?
Lycorine exhibits antiviral (SARS-CoV, H5N1), antitumor (autophagy inhibition, cell-cycle arrest), anti-inflammatory, and AChE inhibitory effects (Murray et al., 2013; Roy et al., 2016; Verma et al., 2020).
What are key methods for studying lycorine activities?
In vitro assays measure IC50 for AChE inhibition (Murray et al., 2013), autophagy flux in myeloma cells (Roy et al., 2016), and viral RNP export blockade (Chen et al., 2012). Molecular docking and HDAC assays elucidate targets (Li et al., 2012).
What are the most cited papers on lycorine?
Murray et al. (2013, 329 citations) on AChE inhibition; Thawabteh et al. (2019, 315 citations) on alkaloids vs. pathogens; Roy et al. (2018, 163 citations) on anticancer potential.
What open problems exist in lycorine research?
Improving bioavailability via semisynthesis (Cao et al., 2013), identifying selective targets beyond HDAC/HMGB1 (Li et al., 2012; Roy et al., 2016), and conducting clinical trials for antiviral/antitumor applications.
Research Chemical synthesis and alkaloids with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Lycorine Biological Activities with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers
Part of the Chemical synthesis and alkaloids Research Guide